Phosphatidylinositol-3-Kinase-AKT pathway, phospho-JUN and phospho-JNK expression in spontaneously arising bovine urinary bladder tumours

Journal of Comparative Pathology

Volumn 143, Issue 2-3, 2010, Pages 173-178

  Corteggio, A ^a   Urraro, C ^a   Roperto, S ^a   Roperto, F ^a   Borzacchiello, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bovine papillomavirus; Bracken fern; E5 oncoprotein; Urinary bladder tumour

Indexed keywords

CYCLIN D3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHO JUN N TERMINAL KINASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN PJUN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER TUMOR; CONTROLLED STUDY; COW; GENE ACTIVATION; GENE OVEREXPRESSION; HISTOLOGY; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; CARCINOMA; CATTLE; CATTLE DISEASES; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; FEMALE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; ONCOGENE PROTEIN P65(GAG-JUN); PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOPROTEINS; URINARY BLADDER NEOPLASMS;

BOS; BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PARVOVIRUS; PTERIDIUM AQUILINUM;

EID: 77954914448     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2010.03.001     Document Type: Article

References (37)

1. Baldassarre G., Belletti B., Bruni P., Boccia A., Trapasso F., et al. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumour cells. Journal of Clinical Investigation 1999, 104:865-874.
2. Boonen G.J., van Oirschot B.A., van Diepen A., Mackus W.J., Verdonck L.F., et al. Cyclin D3 regulates proliferation and apoptosis of leukemic T cell lines. Journal of Biological Chemistry 1999, 274:34676-34682.
3. Borzacchiello G., Roperto F. Bovine papillomaviruses, papillomas and cancer in cattle. Veterinary Research 2008, 39:45-63.
4. Borzacchiello G., Iovane G., Marcante M.L., Poggiali F., Roperto F., et al. Presence of bovine papillomavirus type 2 DNA and expression of the viral oncoprotein E5 in naturally occurring urinary bladder tumours in cows. Journal of General Virology 2003, 84:2921-2926.
5. Borzacchiello G., Mogavero S., De Vita G., Roperto S., Della Salda L., et al. Activated platelet-derived growth factor β receptor expression, PI3K-AKT pathway molecular analysis, and transforming signals in equine sarcoids. Veterinary Pathology 2009, 46:589-597.
6. Borzacchiello G., Russo V., Gentile F., Roperto F., Venuti A., et al. Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor β receptor in naturally occurring bovine urinary bladder tumours. Oncogene 2006, 25:1251-1260.
7. Borzacchiello G., Russo V., Spoleto C., Roperto S., Balcos L., et al. Bovine papillomavirus type-2 DNA and expression of E5 and E7 oncoproteins in vascular tumours of the urinary bladder in cattle. Cancer Letters 2007, 250:82-91.
8. Campo M.S. Bovine papillomavirus: old system, new lessons?. Papillomavirus Research from Natural History to Vaccines and Beyond 2006, 373-383. Caister Academic Press, Norfolk. M.S. Campo (Ed.).
9. Campo M.S., Jarrett W.F., Barron R., O'Neil B.W., Smith K.T. Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Research 1992, 52:6898-6904.
10. Cantley L.C., Neel B.G. New insights into tumour suppression: PTEN suppresses tumour formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:4240-4245.
11. Carvalho T., Naydan D., Nunes T., Pinto C., Peleteiro M.C. Immunohistochemical evaluation of vascular urinary bladder tumours from cows with enzootic hematuria. Veterinary Pathology 2009, 46:211-221.
12. Chen H.C., Guan J.L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:10148-10152.
13. Contreras-Paredes A., De la Cruz-Hernández E., Martínez-Ramírez I., Dueñas-González A., Lizano M. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (AKT/PI3K) signaling pathway. Virology 2008, 383:78-85.
14. Cordova-Alarcon E., Centeno F., Reyes-Esparza J., Garci{dotless}a-Carranca A., Garrido E. Effects of HRAS oncogene on cell cycle progression in a cervical cancer-derived cell line. Archives of Medical Research 2005, 36:311-316.
15. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
16. Di Maio D., Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 2001, 20:7866-7873.
17. Di Maio D., Lai C.C., Mattoon D. The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein. Cytokine and Growth Factor Reviews 2000, 11:283-293.
18. Filipits M., Jaeger U., Pohl G., Stranzl T., Simonitsch I., et al. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. Clinical Cancer Research 2002, 8:729-733.
19. Jiang J., Wei Y., Liu D., Zhou J., Shen J., et al. E1AF promotes breast cancer cell cycle progression via upregulation of cyclin D3 transcription. Biochemical and Biophysical Research Communications 2007, 358:53-58.
20. Kennedy N.J., Davis R.J. Role of JNK in tumor development. Cell Cycle 2003, 2:199-201.
21. Kim S.H., Juhnn Y.S., Kang S., Park W., Sung M.W., et al. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK 1, 2 and PI3K/AKT. Cellular and Molecular Life Sciences 2006, 63:930-938.
22. Kim A.H., Yano H., Cho H., Meyer D., Monks B., et al. AKT-1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 2002, 35:697-709.
23. Kohrenhagen N., Voelker H.U., Schmidt M., Kapp M., Krockenberger M., et al. Expression of transketolase-like 1 (TKTL1) and p-AKT correlates with the progression of cervical neoplasia. Journal of Obstetrics and Gynaecology Research 2008, 34:293-300.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
25. Liu P., Cheng H., Roberts T.M., Zao J.J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nature Reviews Drug Discovery 2009, 8:627-644.
26. Pamukcu A.M., Price J.M., Bryan G.T. Naturally occurring and bracken-fern-induced bovine urinary bladder tumors. Clinical and morphological characteristics. Veterinary Pathology 1976, 13:110-122.
27. Petti L.M., Ricciardi E.C., Page H.J., Porter K.A. Transforming signals resulting from sustained activation of the PDGFβ receptor in mortal human fibroblasts. Journal of Cell Science 2008, 8:1172-1182.
28. Roperto S., Borzacchiello G., Brun R., Leonardi L., Maiolino P., et al. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder. Journal of Comparative Pathology 2010, 142:95-108.
29. Shaw R.J., Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006, 441:424-430.
30. Sherr C.J. The Pezcoller Lecture: cascer cell cycles revisited. Cancer Research 2000, 60:3689-3695.
31. Shin S., Asano T., Yao Y., Zhang R., Claret F.X., et al. Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel AKT-mediated mechanism. Molecular Cancer Research 2009, 7:745-754.
32. Spofford L.S., Abel E.V., Boisvert-Adamo K., Aplin A.E. Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progression. Journal of Biological Chemistry 2006, 281:25644-25651.
33. Vanhaesebroeck B., Waterfield M.D. Signaling by distinct classes of phosphoinositide 3-kinases. Experimental Cell Research 1999, 253:239-254.
34. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nature Reviews Cancer 2002, 2:489-501.
35. Zhang B., Spandau D.F., Roman A. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis. Journal of Virology 2002, 76:220-231.
36. Zhang X.Y., Zhang P.N., Lu X., Sun H. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer. European Journal of Obstetrics, Gynaecology and Reproductive Biology 2008, 139:237-244.
37. Zhu X., Kwon C.H., Schlosshauer P.W., Ellenson L.H., Baker S.J. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Research 2001, 61:4569-4575.